Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Myriad™ Augmented Soft Tissue Reconstruction Registry

NCT: NCT05243966 · RECRUITING

NCT IDNCT05243966
StatusRECRUITING
Start Date2022-01-10
Completion2029-01
SponsorAroa Biosurgery Limited (INDUSTRY)
First posted
Last updated

Brief Summary

This is an observational study designed to evaluate the safety and clinical outcomes of Myriad™ in soft tissue reconstruction procedures. The study will enroll participants who are undergoing a surgical procedure, where the attending physician will use Myriad™ as part of the surgical intervention.

Frequently Asked Questions

What is Myriad™ Augmented Soft Tissue Reconstruction Registry?

Myriad™ Augmented Soft Tissue Reconstruction Registry is a clinical trial registered under NCT05243966. Current status: RECRUITING.

What is the status of NCT05243966?

The current status of NCT05243966 (Myriad™ Augmented Soft Tissue Reconstruction Registry) is: RECRUITING.

When did Myriad™ Augmented Soft Tissue Reconstruction Registry start?

Myriad™ Augmented Soft Tissue Reconstruction Registry started on 2022-01-10.

Related Devices

K171231Endoform Topical MatrixAroa Biosurgery K172318Endoform Silver Dermal TemplateAroa Biosurgery K181935Endoform Reconstructive Template - Non AbsorbableAroa Biosurgery , Ltd. K183398Endoform RestellaAroa Biosurgery , Ltd. K200413SymphonyAroa Biosurgery , Ltd.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑